11
TITLE: Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity  Full Text
AUTHORS: Lopes Marques, M; Pacheco, AR; Peixoto, MJ; Cardoso, AR; Serrano, C; Amorim, Antonio ; Prata, MJ ; Cooper, DN; Azevedo, L ;
PUBLISHED: 2021, SOURCE: HUMAN MUTATION, VOLUME: 42, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
12
TITLE: Compensatory epistasis explored by molecular dynamics simulations  Full Text
AUTHORS: Serrano, C; Teixeira, CSS; Cooper, DN; Carneiro, J; Lopes Marques, M; Stenson, PD; Amorim, Antonio ; Prata, MJ ; Sérgio F. Sousa ; Azevedo, L ;
PUBLISHED: 2021, SOURCE: HUMAN GENETICS, VOLUME: 140, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
13
TITLE: Evolutionary dynamics of the human pseudoautosomal regions  Full Text
AUTHORS: Monteiro, B; Arenas, M; Prata, MJ ; Amorim, Antonio ;
PUBLISHED: 2021, SOURCE: PLOS GENETICS, VOLUME: 17, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 16
IN MY: ORCID
15
TITLE: Insights into the Middle Eastern paternal genetic pool in Tunisia: high prevalence of T-M70 haplogroup in an Arab population
AUTHORS: Elkamel, S; Marques, SL; Alvarez, L; Gomes, V; Boussetta, S; Mourali Chebil, S; Khodjet El Khil, H; Cherni, L; Benammar Elgaaied, A; Prata, MJ ;
PUBLISHED: 2021, SOURCE: SCIENTIFIC REPORTS, VOLUME: 11, ISSUE: 1
INDEXED IN: WOS CrossRef: 2
16
TITLE: Development of an Antisense Oligonucleotide-Mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level
AUTHORS: Matos, L; Vilela, R; Rocha, M; Santos, JI; Coutinho, MF; Gaspar, P; Prata, MJ ; Alves, S;
PUBLISHED: 2020, SOURCE: HUMAN GENE THERAPY, VOLUME: 31, ISSUE: 13-14
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
Page 2 of 15. Total results: 147.